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A DNA variant, rs734232, altering a RUNX1 binding site was recently reported as susceptibility allele at PSORS2
(17q25) in cohorts of psoriasis patients from the US. A testing of this variant in psoriasis patients from Germany did
not conﬁrm this association in 300 trios nor in two case–control studies with 281 patients with psoriasis vulgaris
and 375 patients with psoriatic arthritis, respectively. These results fail to support rs734232 as a psoriasis sus-
ceptibility factor in German psoriasis patients.
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Psoriasis is a human leukocyte antigen (HLA)-associated
inflammatory skin disease that affects about 2% of the
European population. Numerous genetic studies have
confirmed that HLA-C or the neighboring region harbor
the yet unknown main disease-causing variant (PSORS1).
Many other susceptibility loci have been reported during the
last years, whereas a disease-causing variant was not pro-
posed until recently, when Helms et al (2003) described that
single nucleotide polymorphism (SNP) rs734232 in a puta-
tive RUNX1 binding site was strongly associated in a family-
based psoriasis cohort. Association was also present,
though weaker, in a population-based cohort of European
descent. Further functional in vitro studies showed loss of
specific binding of nuclear extracts from a human T cell line
for the associated minor A allele as compared with the ma-
jor G allele.
To test whether rs734232A might be a relevant disease-
causing variant in one of our cohorts, we investigated this
SNP in our set of 300 trios as well as in two new cohorts:
one cohort of 281 single patients with psoriasis vulgaris
without joint affection, the other one comprising 375 single
patients with a rheumatologist’s diagnosis of psoriatic
arthritis.
Due to the known considerable heterogeneity of psoria-
sis, we stratified for an a-helix coiled-coil rod homologue
(HCR)-risk haplotype that is in strong linkage disequilibrium
with the HLA-Cw6 risk allele at PSORS1, as previously de-
scribed by Asumalahti et al (2003). After this stratification
we tested again for association to rs734232.
Results
Association to rs734232 The family-based association
test was informative in 178 (59.3%) of 300 families and gave
no evidence for association to rs734232 (Table I). Likewise,
allele frequencies were similar in the population-based
psoriasis vulgaris and psoriatic arthritis as well as control
cohorts (Table II), again excluding any genetic association.
Hardy–Weinberg equilibrium for rs734232 was confirmed in
all cohorts.
PSORS1-associated risk haplotype In the set of trio index
cases as well as in the patients with psoriasis vulgaris we
found deviation from Hardy–Weinberg equilibrium for two
HCR SNP due to significant excess of patients het-
erozygous for the risk alleles. In contrast, Hardy–Weinberg
equilibrium was confirmed in the patient group with psoria-
tic arthritis. As expected, association to risk alleles of the
two HCR SNPs in the 300 trios was strong: the p-value of
the family-based associaton test (FBAT)-statistics for HCR-
325T was 1.0  106 whereas for HCR-2327G the value
was calculated to be 1.4  105 (196 of 207 informative
families, respectively). In the family study, the index case
carried the HLA-Cw6-associated haplotype in two-thirds of
the families (Table I). In the case–control study, we also
found strong association to the two HCR-SNP whereas in
the patients with psoriasis vulgaris the p-values in the w2
statistic were lower (1.3  1014 for HCR-325T and
1.3  108 for HCR-2327G) than the corresponding p-val-
ues for psoriatic arthritis patients (1.3  107 for HCR-
325T and 4.5  104 for HCR-2327G). In the case–control
study, we noted also a significant difference in the number
of HCRWWCC carriers between the patient cohort with
psoriasis vulgaris without arthritis and the one with psoriatic
Abbreviations: HLA, human leukocyte antigen; SNP, single nuc-
leotide polymorphism
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arthritis (187 subjects (66.5%) vs 198 subjects (53.0%),
w2¼12.0, p¼ 5.3  104).
Association to rs734232 after stratiﬁcation for
PSORS1 Next, we stratified the nuclear families and sin-
gle cases for the risk haplotype HCRWWCC associated to
PSORS1. In the subgroups of nuclear families negative
for the PSORS1-associated risk haplotype, this procedure
resulted in a weak association to the major G allele of
rs734232 (p¼ 0.035). In the psoriatic arthritis patients neg-
ative for the PSORS1-associated risk haplotype, an asso-
ciation to the major G allele was observed (p¼ 3.0  104).
This association remained significant even when corrected
for multiple testing (we corrected for the six tests per-
formed) using the overly conservative Bonferroni correction
(pc¼1.8  103). No changes of association results to
rs734232 could be observed in any of the other subgroups
(Tables I and II).
Power calculation The calculation of the conditional pow-
er in the nuclear families for rs734232 was done for an ad-
ditive model and type I error was set to an a-level of 0.01. A
genetic factor accounting for a relative risk of 1.6 for he-
terozygotes and for a corresponding risk of 2.8 for homo-
zygotes could have been detected with a power of 0.93,
whereas a genetic factor conferring the same relative risk
for heterozygotes and a relative risk of 3.2 for homozygotes
could have been detected with a power of 0.98.
In the population-based study calculation of power was
done under the assumption of an logarithmic additive model
and a type I error rate of 0.05. The number of cases and
controls has adequate power (0.8) to detect a genetic factor
conferring a relative risk of 1.4 in the cohort of patients with
psoriasis vulgaris and a corresponding risk of 1.35 in the
one with psoriatic arthritis patients.
Discussion
To investigate whether rs734232, recently proposed as a
disease-causing variant at PSORS2 (Helms et al, 2003),
might be a relevant genetic factor contributing to psoriasis
in patients from Germany, we tested for association in a
family-based cohort and two case–control studies. We
failed to detect any association to rs734232 and therefore
fail to support that the putative RUNX1 binding site is a
susceptibility factor in the German cohorts studied. To es-
timate whether our cohorts were adequate to detect this
factor, we performed a calculation of conditional power in
the nuclear families using the genotypes observed. Using a
conservative model for an additive effect association could
have been missed for a genetic factor conferring a relative
risk of less than 1.6 in heterozygotes. An estimation of the
power of our population-based cohorts shows that possible
association could have been detected for even smaller rel-
ative risks. The discordance with data from Helms et al
(2003) might be explained by genetic heterogeneity that has
been shown in psoriasis for example in the different linkage
studies for which replication was seldom possible.
PSORS1 is the major disease-causing factor in the ge-
netics of especially the early onset form of psoriasis. We
have previously reported association to HLA-Cw6 in a sub-
group comprising 52 of 210 trios (Schmitt-Egenolf et al,
Table I. Allele frequencies of rs734232 in nuclear families and
results of family-based association test (FBAT)
Allele
fre-
quency
for
allele Ga
Allele
fre-
quency
for
allele Aa
Number
of infor-
mative
families Z
p-
value
300 nuclear
families
0.550 0.450 178 (59.3%) 1.174 0.240
203 families
with index
positive for
HCR
WWCCb
0.550 0.450 123 (61.8%) 0.025 0.980
97 families
with index
negative for
HCR
WWCCb
0.550 0.450 55 (59.1%) 2.111 0.035
aAllele frequency in parents.
bPSORS1 risk haplotype.
Table II. Allele frequencies of rs734232 in single cases and
controls and results of v2 statistics
Proband
group
Allele
frequency
for allele G
Allele
frequency
for allele A v2a p-valuea
Psoriasis
vulgaris
290 (52.5%) 262 (47.5%) 0.030 0.863
Controls 381 (52%) 351 (48%)
Psoriatic
arthritis
411 (56.8%) 313 (43.2%) 3.267 0.071
Psoriasis
vulgaris,
positive for
HCRWWCCb
195 (52.4%) 177 (47.6%) 0.782 0.376
Psoriasis
vulgaris,
negative
for HCR
WWCCb
95 (52.8%) 85 (47.2%) 1.480 0.224
Controls,
positive
for HCR
WWCCb
126 (48.8%) 132 (51.2%)
Controls,
negative
for HCR
WWCCb
223 (47.4%) 247 (52.6%)
Psoriatic
arthritis,
positive
for HCR
WWCCb
204 (53.7%) 176 (46.3%) 1.446 0.229
Psoriatic
arthritis,
negative
for HCR
WWCCb
207 (60.2%) 137 (39.8%) 12.911 0.0003
aCompared with genotype frequencies in controls.
bPSORS1 risk haplotype.
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2001) as well as to marker tn62 adjacent to HLA-C in the full
set of 210 trios (Hensen et al, 2003a). We could also detect
association to several regions on chromosome 19 in this
cohort (Hensen et al, 2003b) corresponding to or adjacent
to a region for which we previously reported linkage in an
independent set of families (Lee et al, 2000). In the set of
trios that we could extend to 300 nuclear families in the
meantime, we found strong association to the two HCR
SNP tested. Therefore we could confirm that PSORS1 is a
relevant susceptibility locus in this study group.
About two-thirds of trios as well as of single cases and
more than half of patients with psoriatic arthritis are positive
for the HCR-risk haplotype, which was used as an indirect
measure of the PSORS1 risk allele. The HCR-risk haplotype
HCRWWCC as previously described by Asumalahti et al
(2003) is in strong linkage disequilibrium to the HLA-Cw6
allele and might therefore serve as an estimate of the
PSORS1 risk allele, even when the presence of this haplo-
type on some non-risk haplotypes at PSORS1 is known
(Chia et al, 2001). Our proportion of patients with psoriasis
vulgaris carrying the PSORS1-associated risk allele is in the
same range as data from other studies (Enerback et al,
1997; Queiro et al, 2003) that is suggestive of a good ap-
proximation of the used method to characterize the
PSORS1 risk allele. The finding of a significant percentage
of patients with psoriatic arthritis positive for the PSORS1
risk allele has been known from several studies (Murray
et al, 1980; Beaulieu et al, 1983; Gladman et al, 1986). The
large overlap of patients with and without arthritis carrying
the PSORS1-associated HCR-risk haplotype suggests sim-
ilar genetic factors in both groups. Nevertheless, the signif-
icant difference in PSORS1-associated risk allele frequency
between the two patient groups might also indicate different
genetic factors contributing to the arthropathy.
We further investigated whether association to PSORS2
might be detected after stratification to PSORS1. Stratifi-
cation of cohorts for the HLA-Cw6-associated HCR-risk
haplotype indicated an association to the wild-type G allele
in the subgroup of patients negative for the PSORS1 risk
allele in the psoriatic arthritis group. This could mean that in
this group of patients a different variant in linkage disequi-
librium with the G allele is associated with the disease. Ha-
plotype analyses are required to confirm or refute this
hypothesis. No evidence for association in any of the other
subgroups was found (Tables I and II).
In summary, our results fail to support the putative dis-
ease-causing variant rs734232A as a psoriasis suscepti-
bility factor in psoriasis patients of German origin.
Material and Methods
Patients Approval for the studies was obtained through the ethical
committee of the Universities of Mu¨nster and Erlangen and the
individuals gave their written informed consent. The investigations
were conducted according to the Declaration of Helsinki principles.
We investigated the formerly described cohort of 210 trios with
psoriasis from Northern Germany (Hensen et al, 2003b) that we
could expand to 300 nuclear families in the meanwhile. All index
cases had an early onset form of psoriasis vulgaris with medium
age of onset of 16.2  9.1 y. 53.3% of index patients were male. In
61% of trios, the father and/or the mother were also affected by
psoriasis.
The 281 single patients with psoriasis vulgaris were recruited
through dermatology clinics at two psoriasis rehabilitation hospi-
tals. An early onset form of psoriasis was diagnosed in all but three
patients with a medium age of onset of 21.3  9.4 y. The majority
of patients suffered from plaque type of psoriasis vulgaris. We
excluded all patients with signs of psoriatic arthritis until the time of
recruitment when medium age was 48  11.1 y. Sixty-one percent
of patients were male.
The 375 patients with psoriatic arthritis were recruited through
four different rheumatological centers in Germany; the centers
were one acute clinic, two rehabilitation hospitals and one pri-
vate practice. Medium age of onset for psoriasis vulgaris was
30.1  13.0 y; 59.9% of patients were male. For 78% of the pa-
tients, the diagnosis of psoriatic arthritis was made X3 y prior to
recruitment. Peripheral joint involvement was detectable in the
majority of cases (343 or 91.4%), presenting in 85 (22.6%) patients
as an oligoarthritis (affecting less than five joints) whereas polyar-
ticular disease was recorded in 258 (68.8%) single cases. In 67%
of patients with polyarthritis joint erosions were detectable by X-ray
as signs of a destructive course of the disease as well as in 26%
of oligoarthritis patients. Spinal involvement in form of typical
spondyloarthritis and/ or sacroiliitis was observed in 72 cases
(19%).
The 376 controls had no psoriasis vulgaris at the time of re-
cruitment when medium age was 32  10 y. All of them were
healthy blood donors and recruited in Northern Germany. 58.7% of
probands were male.
Genotyping We genotyped all SNP with Taqman assays on
7900HT Sequence Detection System (Applied Biosystems, Foster
City, California). Sequences of primers and probes are given in the
supplementary Table S1. Only SNPs with a genotyping rate of
497% were included. Taqman genotypes for all SNPs could be
confirmed through direct sequencing in a set of 48 randomly cho-
sen probands.
Statistical analysis Association within the nuclear families was
calculated using the family-based association test (FBAT, Laird
et al, 2000). Haplotype reconstruction for the two HCR SNPs in the
trio index cases was done with the program PHASE (Stephens
et al, 2001) to allow stratification for HCR haplotype.
To determine significant differences in allele frequencies be-
tween the proband groups, a w2 statistics was used. All SNPs
were tested for Hardy–Weinberg-equilibrium. Haplotypes of the
HCR gene in case groups were also reconstructed with PHASE
(Stephens et al, 2001).
Power calculation The conditional power to detect association
to rs734232 in the nuclear families was calculated as described
by Knapp (Knapp, 1999). To test whether our sample sizes of
single cases and controls are sufficient to detect association to
rs734232, we used the program QUANTO Version 0.5 (Gauderman,
2002).
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